A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant.
Completed
Idorsia Pharmaceuticals Ltd.
Phase 1
2020-05-13
A study in healthy male subjects to investigate the effect of famotidine and efavirenz on the
way the body takes up, distributes, and gets rid of daridorexant.
Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder
Not yet recruiting
Idorsia Pharmaceuticals Ltd.
Phase 2
2022-07-01
This study assesses the efficacy, safety, and pharmacokinetics of multiple-dose oral
administration of daridorexant in pediatric subjects aged 10 to < 18 years with insomnia
disorder.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
